Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86914 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86917 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86920 |
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-04 | 2019-11-22 | 68580 |
OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2019-09-12 | 2019-11-22 | 93650 |
TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2019-10-24 | 2019-11-28 | 97153 |
TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2019-10-10 | 2019-11-28 | 96076 |
TEVA-VORICONAZOLE | 200MG | TABLET | Resolved | 2019-08-22 | 2019-11-28 | 92163 |
TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2019-11-28 | 2019-12-06 | 99947 |
TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2019-09-05 | 2019-12-19 | 93131 |
TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2019-06-18 | 2019-12-19 | 86859 |
TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2019-06-18 | 2019-12-19 | 86879 |
TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2019-09-26 | 2019-12-19 | 94843 |
TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2019-06-13 | 2019-12-19 | 86611 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2019-10-17 | 2019-12-19 | 96717 |
TEVA-CAPTOPRIL | 25MG | TABLET | Resolved | 2019-10-31 | 2020-01-09 | 97611 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2019-08-22 | 2020-01-09 | 92140 |
FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-11-21 | 2020-01-09 | 99441 |
ACT MELOXICAM | 7.5MG | TABLET | Actual shortage | 2020-01-09 | 2020-01-09 | 102935 |
TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2019-09-26 | 2020-01-17 | 94867 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |